Kimberly Cramer-Morales

O2⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate

Joshua D. Schoenfeld, Zita A. Sibenaller, Kranti A. Mapuskar et al. · Cancer Cell · 2017 · 438 citations · Full text

Life Sciences, Cancer Biology, Oncology +14

Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile

Kimberly Cramer-Morales, Margaret Nieborowska-Skorska, Kara Scheibner et al. · Blood · 2013 · 144 citations · Full text

Medicine, Cancer Biology, Oncology +16

Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells

Margaret Nieborowska-Skorska, Katherine Sullivan, Yashodhara Dasgupta et al. · Journal of Clinical Investigation · 2017 · 76 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Identification of a Small Molecule Inhibitor of RAD52 by Structure-Based Selection

Katherine Sullivan, Kimberly Cramer-Morales, Daniel L. McElroy et al. · PLoS ONE · 2016 · 63 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +17

SOD2 targeted gene editing by CRISPR/Cas9 yields Human cells devoid of MnSOD

Kimberly Cramer-Morales, Collin D. Heer, Kranti A. Mapuskar et al. · Free Radical Biology and Medicine · 2015 · 39 citations

Life Sciences, Genetics, Molecular Biology +13